Literature DB >> 3407264

[Experimental study of the effect of raw materials of the neem tree and neem extracts on dermatophytes, yeasts and molds].

M Khan1, B Schneider, S W Wassilew, V Splanemann.   

Abstract

In traditional Indian medicine, various parts of the neem tree have been used for centuries, especially with skin diseases. These products are often applied in human mycoses. We tested some dried neem materials, neem oils as well as simple neem preparations and extracts with regard to their effect on 14 of the most common pathogenic fungi. Neither the dried neem materials nor the medical preparations and oils had any effect on fungal growth; most of them were even contaminated with molds. Some of the extracts, however, showed antimycotic properties, which decreased with rising solvent polarity. Petrolether leaf extract proved most effective. One of the possible explanations might be the fact that it contains quercetin, a flavonoid.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407264

Source DB:  PubMed          Journal:  Z Hautkr        ISSN: 0301-0481


  4 in total

Review 1.  Review on pharmacological and toxicologyical effects of oleum azadirachti oil.

Authors:  Khaled M M Koriem
Journal:  Asian Pac J Trop Biomed       Date:  2013-09-04

2.  Morphological alterations in toxigenic Aspergillus parasiticus exposed to neem (Azadirachta indica) leaf and seed aqueous extracts.

Authors:  Mehdi Razzaghi-Abyaneh; Abdolamir Allameh; Taki Tiraihi; Masoomeh Shams-Ghahfarokhi; Mehdi Ghorbanian
Journal:  Mycopathologia       Date:  2005-06       Impact factor: 2.574

3.  Effects of neem leaf extract on production of aflatoxins and activities of fatty acid synthetase, isocitrate dehydrogenase and glutathione S-transferase in Aspergillus parasiticus.

Authors:  A Allameh; M Razzaghi Abyane; M Shams; M B Rezaee; K Jaimand
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

4.  Therapeutic Potential of Plants as Anti-microbials for Drug Discovery.

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone
Journal:  Evid Based Complement Alternat Med       Date:  2008-06-24       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.